Results 231 to 240 of about 441,361 (298)

Trends and Disparities in Ventricular Tachycardia-Related Mortality According to Cardiomyopathy Type in the United States. [PDF]

J Cardiovasc Electrophysiol
Sheffeh MA, du Fay de Lavallaz J, Magana AE, Siontis KC, Liang JJ.   +4 more
europepmc   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source

Echocardiographic Features of Cardiomyopathies: A Comprehensive Review. [PDF]

Echocardiography
Al-Naami GH.
europepmc   +1 more source

Serial Assessment of Extracellular Volume Fraction Derived on Coronary Computed Tomography Angiography in Takotsubo Cardiomyopathy

Hiroki Ueno, Yoshihisa Kanaji, Eisuke Usui, Masahiro Hada, Tsunekazu Kakuta   +4 more
openalex   +1 more source

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

Nature Reviews Endocrinology, 2016
Guanghong Jia, V. DeMarco, J. Sowers
semanticscholar   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Relationships between QRS duration and left ventricular deformation in hypertrophic cardiomyopathy. [PDF]

Quant Imaging Med Surg
Chen S, Duan M, Zhao X, Zhang D, Qin H, An S, Gao B, Zhao X.   +7 more
europepmc   +1 more source

A double-blind, randomised placebo-controlled trial examining the effect of MitoQ on myocardial energetics in patients with dilated cardiomyopathy

Brian P Halliday, Ruth Owen, Aaraby Ragavan, Katherine L. Smith, Ben Statton, Alaine Berry, Alex Kasiakogias, Zoi Tsoumani, Mayooran Shanmugnathan, Jason N Dungu, Antonio de Marvao, Upasana Tayal, James S. Ware, Declan P. O'Regan, Dudley J Pennell, John G. F. Cleland, Sanjay K. Prasad, John Gregson, Michael P. Murphy, Oliver Rider, Ladislav Valkovic   +20 more
openalex   +1 more source

Mid‐term survival in patients awaiting heart and kidney transplantation with Impella 5.5 support

ESC Heart Failure, EarlyView.
Abstract Background Patients with end‐stage heart failure and chronic kidney disease requiring dual‐organ transplantation (DOT) face significant challenges in utilizing durable mechanical circulatory support due to the risks associated with renal replacement therapies (RRTs) and multi‐organ failure.
Smruti Desai, Smit Paghdar, Jose Ruiz, Ji‐Min Jang, Sharan Malkani, Daniel S. Yip, Juan Leoni, Jose Nativi, Basar Sareyyupoglu, Kevin Landolfo, Si Pham, Parag Patel, Rohan Goswami   +12 more
wiley   +1 more source

Anesthetic management and outcomes in patients undergoing epicardial ablation for the treatment of ventricular tachycardia: A retrospective analysis. [PDF]

Medicine (Baltimore)
Yaman F, Akyüz T, Çamli Babayiğit E, Ulus T.   +3 more
europepmc   +1 more source